Biotherapeutics encompasses the medicinal use of therapeutically active agents and products that are produced through biological means.  It includes biologics, plasma-derived therapies, immune suppressants, interferon, chemotherapy agents, biologic response modifiers, recombinant products, vaccines. These products are used to therapeutically treat and manage the conditions of illnesses and diseases. 

Biotherapeutic agents are made to be administered by a variety of means, including oral, injectible, infusible, inhalation, subdermal, subcutaneous, direct application, and respiratory tract absorption.  They can also be administered through the use of artificial, in-vivo delivery devices.  Biotherapeutic agents generally do not include traditional allopathic pharmacologic agents or cellular therapies unless their primary or secondary effects are determined to have similar properties. Therefore, there are no generic alternatives for these therapies.

>> View the IVIG Access Report video

>> View the video on the IVIG California Campaign

Members of the immune globulin community have united to form the Alliance for BioTherapeutics, because patient care has been compromised by lack of access to intravenous immune globulin (IVIG); many providers are no longer treating with IVIG due to reimbursement restrictions; and no other organization exists to represent all patients and providers of plasma therapies.

>> Learn more about the IVIG crisis